Pharmacists in Coralville, IA Accepting Medicare

64 Pharmacists found. Showing 61 - 64

Bridgette Cochran Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2751 Heartland Dr, Coralville, IA 52241 Phone: 319-545-4600    Fax: 319-545-4606

Tatum Meyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3285 Crosspark Rd, Coralville, IA 52241 Phone: 319-665-2078

Mrs. Tina Jo Telander, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2801 Commerce Dr, Coralville, IA 52241 Phone: 319-545-6412    Fax: 319-545-6415

Jody Siegrist Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 2nd St, Coralville, IA 52241 Phone: 319-341-6153

News Archive

IsoNTech to showcase latest advances in safer, alternative nicotine products

The First International Symposium on Nicotine Technology takes place today in Warsaw, Poland. The symposium looks at new and emerging technologies in the area of nicotine delivery and will be showcasing the latest advances in alternative nicotine delivery systems, next generation devices, and the science behind them.

Collaborative center established to reduce obesity-related deaths in African-American and Latino communities

A $6 million grant from the National Heart, Lung and Blood Institute (NHLBI) has funded the creation of ORBIT: Obesity Related Behavioral Intervention Trials to focus on reducing obesity and obesity-related deaths in New York City's African-American and Latino communities.

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA (HE4 EIA + ARCHITECT CA 125 II) to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

GPEC receives unrestricted grant of $250,000 to study new treatments for breast cancer

Located at Vancouver General Hospital and a partner of the BC Cancer Agency, the Genetic Pathology Evaluation Centre, led by three prominent pathologists, is a recognized world leader in cancer research in the area of biomarker technology. Today, with an additional unrestricted grant of $250,000 from sanofi-aventis, GPEC is ready to make even more scientific breakthroughs.

Study pinpoints genetic factors behind increased ALL risk in Hispanic children

Hispanic children are more likely than those from other racial and ethnic backgrounds to be diagnosed with acute lymphoblastic leukemia (ALL) and are more likely to die of their disease. Work led by St. Jude Children's Research Hospital scientists has pinpointed genetic factors behind the grim statistics.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3
• 4(current)